Group B opening statement at 2009 WIPO GA
In WIPO, Group B is a club of high income countries. This is the statement Group B delivered in the Agenda item for general statements, at the 2009 WIPO GA.
47th Series of Meetings of WIPO
Geneva, September 22 to October 1, 2009
Group B: opening statement
Mr. Chairman
2009 WIPO General Assembly begins
Every year at the end of September, the World Intellectual Property Organization (WIPO) holds a General Assembly (GA). The GA hears reports from all WIPO committees, approves budgets and top staff appointments, and sets the agenda for the next year. This year’s GA started today, with a large number of patent and copyright office heads, trade negotiators and NGOs in attendance.
March 28, 2001 Letter to US Secretary of Health and Human Services Tommy Thompson regarding access to NIH funded patents
March 28, 2001
Secretary Tommy Thompson
Department of Health and Human Services
200 Independence Avenue, SW
Washington, DC 20201
Dear Mr. Thompson:
Humanitarian Uses of Patented Inventions
This note concerns two areas of policy concerning humanitarian uses of patents. (1), a recommended exception to patent rights for humanitarian uses, and (2), the licensing of patents for humanitarian uses. Both examples focus on access to essential medical technologies.… Continue Reading
Research Exemption
- July 7, 2008, The Patent Research Exception: An Informal Consultation, UK Intellectual Property Office.
- Geertrui Van Overwalle & Esther van Zimmeren (Centre for Intellectual Property Rights, University of Leuven, Belgium),”Reshaping Belgian Patent Law: The Revision of the Research Exemption and the Introduction of a Compulsory License for Public Health”, Chizaiken Forum vol.64, Winter 2006, pp.42-49
KEI Brownbag on Bilski case: Scope of Patentable Subject Matter
Date: September 10, 2009
On September 10, 2009 KEI hosted a brownbag lunch to discuss the scope of patentable subject matter, focusing specifically on the implications for life-science patents of the Supreme Court’s forthcoming review of the Bilski Federal Circuit opinion. This is the first time since 1981 that the US Supreme Court will address the limits of patentable subject matter.
The key U.S. statue on this issue is Section 101 of the patent law:
35 USC 101. Inventions patentable
Obama Administration role in the regulation of prices for medicine and medical devices in Japan
On July 6, 2009, a report of the the U.S.-Japan Regulatory Reform and Competition Policy Initiative was presented to President Obama and Prime Minister Aso of Japan. The report provides an insight into the degree that the U.S. government tries to influence prices for medicines and medical devices in foreign markets. Here, as in other foreign markets, the U.S. government seeks to raise prices, and to give industry an even greater role in setting the prices for their products.
NYT: PhRMA to support Baucus version of health bill
According to a report by Duff Wilson in the Sunday New York Times, Much of PhRMA’s $150 million in advertising will be spent pushing Senator Baucus’s version of the health “reform” legislation.
KEI June 19, 2007 Statement on WIPO Broadcasting Treaty
Tuesday, 19 June 2007
(See also the KEI web page on the WIPO broadcast treaty).
19 June 2007
WIPO Broadcasting Treaty
For older documents, see CPTech webpage on WIPO Broadcasting Treaty
For commentary, including breaking developments, see KEI blogs on the treaty.